GenmabGMAB 
$26.20-0.87%24h
-0.87%24h
Global rank998
Market cap$17.11B
Change 7d-1.73%
YTD Performance-16.43%
SP500 benchmarkUnderperform
P/E3.97
P/S6.97
Revenue$2.45B
Earnings$648.34M
Dividend yield-
Main Sector
Healthcare
Genmab (GMAB) Cash on Hand
GMAB Cash on Hand in 2022: $4.19B
According to Genmab latest financial reports the cash on hand of GMAB is $4.19B, an increase of 26.03% to 2022. At the end of 2022 company had $3.33B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
GMAB Cash on Hand History from 2018 to 2023
-
Value:-
GMAB Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $4.19B | 26.03% |
| 2022 | $3.33B | 15.44% |
| 2021 | $2.88B | 20.27% |
| 2020 | $2.40B | 46.56% |
| 2019 | $1.63B | 79.67% |
| 2018 | $909.66M | - |
View the Top Cash on Hand Companies 
